일라이 릴리는 주사 공급 부족을 극복하기 위해 노력하면서 현재 환자들에게 체중 감량 의약품인 Zepbound의 바이알을 판매하고 있습니다. 블룸버그 인텔리전스 수석 제약-바이오텍 분석가인 마이클 샤가 블룸버그 인텔리전스에 합류하여 이것이 앞으로 체중 감량 산업에 어떤 의미가 있는지 분석합니다.
——–
애플의 블룸버그 인텔리전스 팟캐스트에 대한 자세한 내용: http://bit.ly/3YrBfOi On Spotify: http://bit.ly/3SPPZ8F Anywhere: http://bit.ly/43hOc0r Follow us on X: https://twitter.com/BloombergRadio Bloomberg Business 앱으로 Apple CarPlay 및 Android Auto에 대해 들어보세요: Apple CarPlay: https://apple.co/486mghI Android Auto: https://bit.ly/49benZy 당사 유튜브 채널을 방문하세요: 블룸버그 팟캐스트: https://www.youtube.com/bloombergpodcasts Bloomberg Television: https://www.youtube.com/ @markets Bloomberg Originals: https://www.youtube.com/bloomberg Quicktake: https://www.youtube.com/ @
Eli Lilly is now selling vials of its weight-loss drug Zepbound to patients as it works to overcome supply shortages of their shots. Michael Shah, Bloomberg Intelligence Senior Pharma-Biotech Analyst, joins Bloomberg Intelligence breaks down what this means for the weightloss industry going forward.
——–
Get more on The Bloomberg Intelligence Podcast
On Apple: http://bit.ly/3YrBfOi
On Spotify: http://bit.ly/3SPPZ8F
Anywhere: http://bit.ly/43hOc0r
Follow us on X: https://twitter.com/BloombergRadio
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay: https://apple.co/486mghI
Android Auto: https://bit.ly/49benZy
Visit our YouTube channels:
Bloomberg Podcasts: https://www.youtube.com/bloombergpodcasts
Bloomberg Television: https://www.youtube.com/@markets
Bloomberg Originals: https://www.youtube.com/bloomberg
Quicktake: https://www.youtube.com/@BloombergQuicktake
